Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 386 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
First-line Biological Versus Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy in Adult-Onset Still's Disease: a Multicentre, Retrospective, Propensity Weighted Cohort Study
Anna Kernder, Tim Filla, Rhea Friedrich,Norbert Blank,Diana Ernst, Jörg Henes,Gernot Keyßer,Philipp Klemm,Martin Krusche, Anna Meinecke,Jürgen Rech, Nils Schulz, Simon Michael Petzinna,Anne Pankow,Valentin S Schäfer,Alexander Pfeil, Sebastian Klapa,Eugen Feist, Stefan Vordenbäumen
The Lancet Rheumatologyno. 6 (2025): e415-e423
Cited0Views0WOSBibtex
0
0
Deoxygenation Trends and Their Multivariate Association with Self-Reported Fatigue in Post-COVID Syndrome
Anja-Maria Ladek,Marianna Lucio, Andreas Weiß, Thomas Knauer, Helena Sarmiento, Miriam Ilgner, Marie Jakobi, Laura Barteczko, Marion Ganslmayer,Jürgen Rech,Antonio Bergua, Christian Y. Mardin,Bettina Hohberger
Biomedicines (2025)
Cited0Views0Bibtex
0
0
OP0006 CHARACTERISATION OF GENETIC LANDSCAPE AND NOVEL INFLAMMATORY BIOMARKERS IDENTIFIES NOVEL TREATMENT TARGETS IN ADULT-ONSET STILL’S DISEASE
Chang L.,Topping J.,Nadat F.,Poulter J., Watson C., Carter C., Pournara L.,Zernicke J., Ross R.,Cargo C., Del Galdo F.,Rech J.,Fautrel B.,Feist E.,Mcdermott M., Savic S.
Annals of the Rheumatic Diseases (2024): 200-201
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 386

#Citation: 9560

H-Index: 49

G-Index: 92

Sociability: 7

Diversity: 3

Activity: 50

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn